Generated by Yoast SEO v26.5, this is an llms.txt file, meant for consumption by LLMs.

The XML sitemap of this website can be found by following [this link](https://clinicaltrials.servier.com/sitemap_index.xml).

# Clinical Trials

## Pages
- [Politique de confidentialité](https://clinicaltrials.servier.com/fr/declaration-de-confidentialite/)
- [Privacy Policy:](https://clinicaltrials.servier.com/privacy-notice/)
- [Conditions d'utilisation](https://clinicaltrials.servier.com/fr/conditions-dutilisation/)
- [Terms of use](https://clinicaltrials.servier.com/terms-of-use/)
- [Nos engagements en matière de R\&D](https://clinicaltrials.servier.com/fr/nos-engagements-en-matiere-de-rd/)

## Study
- [Combinaison d'Ivosidenib, Nivolumab et Ipilimumab chez des sujets précédemment traités atteints de cholangiocarcinome mutant IDH1 non résécable ou métastatique\.](https://clinicaltrials.servier.com/fr/trial/combinaison-divosidenib-nivolumab-et-ipilimumab-chez-des-sujets-precedemment-traites-atteints-de-cholangiocarcinome-mutant-idh1-non-resecable-ou-metastatique/)
- [A study to evaluate the efficacy and safety of gliclazide MR in patients with type 2 diabetes inadequately controlled with dapagliflozin with or without metformin](https://clinicaltrials.servier.com/trial/a-study-to-evaluate-the-efficacy-and-safety-of-gliclazide-mr-in-patients-with-type-2-diabetes-inadequately-controlled-with-dapagliflozin-with-or-without-metformin/)
- [A Phase Ib/II first\-in\-human, multicentre, open\-label, multiple ascending dose study of S230815 in paediatric participants with KCNT1\-related Developmental and Epileptic Encephalopathy](https://clinicaltrials.servier.com/trial/a-phase-ib-ii-first-in-human-multicentre-open-label-multiple-ascending-dose-study-of-s230815-in-paediatric-participants-with-kcnt1-related-developmental-and-epileptic-encephalopathy/)
- [Première étude chez l’homme de phase Ib/II, multicentrique, en ouvert, à doses multiples croissantes, portant sur le S230815 chez des participants pédiatriques atteints d’encéphalopathie épileptique et développementale liée à KCNT\-1](https://clinicaltrials.servier.com/fr/trial/premiere-etude-chez-lhomme-de-phase-ib-ii-multicentrique-en-ouvert-a-doses-multiples-croissantes-portant-sur-le-s230815-chez-des-participants-pediatriques-atteints-dencephalopath/)
- [Multiple\-Dose Study on the Bioequivalence of One  Tablet of Gliclazide MR 120 mg \(S005190\) and Two  Tablets of Gliclazide MR 60 mg \(Diaprel® MR\) in  Healthy Participants under Fed Conditions\.](https://clinicaltrials.servier.com/trial/multiple-dose-study-on-the-bioequivalence-of-one-tablet-of-gliclazide-mr-120-mg-s005190-and-two-tablets-of-gliclazide-mr-60-mg-diaprel-mr-in-healthy-participants-under-fed-conditions/)